{
  "id": 17736024,
  "title": "Computational Repurposing of FDA Approved Drugs Against Cyclin Dependent Kinase (CDK2)",
  "url": "https://urgent.news/2026/11/01/computational-repurposing-of-fda-approved-drugs-against-cyclin",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-01T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.10.27.762194v1?rss=1"
  },
  "original_language": "en",
  "account": null,
  "summary": "Drug repurposing is an approach for identifying new therapeutic with existing FDA approved drugs. Cyclin-dependent kinase 2 (CDK2) is an important regulator of cell cycle progression. The present study aimed to identify FDA-approved drugs with potential binding activity against CDK2 using a Computational drug-repurposing approach. The crystal structure of Human CDK2 (PDB ID: 3PY0) was used for…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}